Lupin gets FDA nod for oral contraceptive

Tags: News
Mumbai-headquartered Lupin has received approval from food and drugs administration (USFDA) to sell generic version of Watson Laboratories’ Lutera tablets. Lutera is an oral contraceptive drug.

The move will help company strengthen its oral contraceptive product basket. It is Lupin’s seventh oral contraceptive product approved by the USFDA. US is the largest drug market in the world and accounts for about one-third of volumes for the company. Oral contraceptive is less competed for segment. There are just three players in the market for this product: Vintage, Teva and Watson. Lupin’s has filed 32 products in the oral contraceptive segment with the FDA and waiting for approval.

Lupin’s levonorgestrel and ethinyl estradiol tablets, having strength of 0.1 mg and 0.02 mg, are combined oral contraceptives prescribed for the prevention of pregnancy in women who choose to use oral contraceptives as a method of avoiding pregnancy.

“Lutera had annual US sales of approximately $103.6 million. Lupin will be marketing its generic product shortly,” said a company statement. The generic market for oral contraceptives is estimated at $1.2 billion.

Last month, Lupin received approval from USFDA for its oral contraceptive drug Yasmin that had annual sales of $275 million in the US.

In the quarter that ended September 30 Lupin reported consolidated revenue of Rs 2,301 crore with net profit of Rs 290 crore. The company is expected to declare its quarterly result on January 31.

shutiverma@mydigitalfc.com

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • E-auction and eventual privatisation of coal industry are welcome steps

    The government’s decision to privatise the scam-ridden coal industry through a presidential ordinance will eventually end the monopoly of public sec

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Tushar Gandhi

Sustainable model for rural sanitation

Prime minister Narendra Modi has promised to build a toilet ...

Rajgopal Nidamboor

Synchronous balance is vital for one and all

Imagine that you are playing an electronic game, or actually ...

Shona Adhikari

When women to birds become a painter’s muses

This week the focus is on renowned artist Amitabha Banerjee, ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture